Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
Public ClinicalTrials.gov record NCT00631371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3b, Randomized, Open-Label Study Of Bevacizumab + Temsirolimus Vs. Bevacizumab + Interferon-Alfa As First-Line Treatment In Subjects With Advanced Renal Cell Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary objective: Comparison of independently assessed progression free survival (PFS) in subjects administered Bevacizumab + Temsirolimus vs. those administered Bevacizumab + Interferon-Alfa. Secondary objectives: safety, Investigator assessed PFS, objective response rate (independently assessed), and overall survival.
Study identification
- NCT ID
- NCT00631371
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 791 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Apr 2012 (Actual)
- Completion
- Apr 2015 (Actual)
- Last update posted
- Apr 27, 2016
2008 – 2015
United States locations
- U.S. sites
- 25
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology Oncology Services of Arkansas | Little Rock | Arkansas | 72205 | — |
| South County Hematology/Oncology | Chula Vista | California | 91911 | — |
| Cancer Center Oncology Medical Group | La Mesa | California | 91942 | — |
| UCLA Medical Center | Los Angeles | California | 90095-1694 | — |
| UCLA | Los Angeles | California | 90095-6984 | — |
| UCLA | Los Angeles | California | 90095 | — |
| North County Oncology Medical Clinic | Oceanside | California | 92056 | — |
| Medical Oncology Associates - SD | San Diego | California | 92123 | — |
| Sharp Memorial Hospital Investigational Pharmacy | San Diego | California | 92123 | — |
| Sharp Rees-Stealy | San Diego | California | 92123 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| Pacific Hematology/Oncology Associates | San Francisco | California | 94115 | — |
| San Francisco Oncology Associates | San Francisco | California | 94115 | — |
| Cohen & Hufford MD's INC | San Francisco | California | 94118 | — |
| The Jones Clinic, PC | New Albany | Mississippi | 38652 | — |
| The Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Edmond Oncology Center | Edmond | Oklahoma | 73034 | — |
| OU Medical Center | Oklahoma City | Oklahoma | 73104 | — |
| OU Physician's Building | Oklahoma City | Oklahoma | 73104 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| The Jones Clinic, PC | Germantown | Tennessee | 38138 | — |
| The Vanderbilt Clinic | Nashville | Tennessee | 37232 | — |
| University of Washington Medical Center | Seattle | Washington | 96195 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109-1023 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 147 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00631371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00631371 live on ClinicalTrials.gov.